Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Healthcare Workers before the Era of Vaccination at a Tertiary Care Hospital in Turkey

被引:7
|
作者
Sonmezer, Meliha Cagla [1 ]
Erul, Enes [2 ]
Sahin, Taha Koray [2 ]
Rudvan Al, Ipek [1 ]
Cosgun, Yasemin [3 ]
Korukluoglu, Gulay [3 ]
Zengin, Humeyra [1 ]
Telli Dizman, Guelcin [1 ]
Inkaya, Ahmet Cagkan [1 ]
Unal, Serhat [1 ]
机构
[1] Hacettepe Univ, Infect Dis & Clin Microbiol Dept, Fac Med, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Internal Med Dept, Fac Med, TR-06100 Ankara, Turkey
[3] Natl Arboviruses & Viral Zoonot Dis Lab, Microbiol Reference Labs Dept, Publ Hlth Gen Directorate Turkey, TR-06100 Ankara, Turkey
关键词
COVID-19; healthcare workers; before vaccination; seroprevalence; SARS-Co-V; 2; antibody; COVID-19;
D O I
10.3390/vaccines10020258
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Healthcare workers (HCWs), as frontliners, are assumed to be among the highest risk groups for COVID-19 infection, especially HCWs directly involved in patient care. However, the data on the COVID-19 infection and seroprevalence rates are limited in HCWs. Therefore, we aimed to evaluate the seroprevalence rates in HCWs according to risk groups for COVID-19 contraction in a large cross-sectional study from a tertiary care hospital in Turkey. We enrolled 1974 HCWs before the vaccination programs. In two separate semi-quantitative ELISAs, either IgA or IgG antibodies against SARS-CoV-2 spike protein subunit 1 (S1) were measured. The proportion of positive test results for IgG, IgA, or both against SARS-CoV-2 of study subjects was 19% (375/1974). Frontline HCWs who had contact with patients (21.7%, RR 2.1 [1.51-2.92]) and HCWs in working in the COVID-19 units, intensive care units, or emergency department (19.7%, RR 1.61 [1.12-2.32]) had a notably higher Anti-SARS-CoV-2 IgG compared to the rest of HCWs who has no daily patient contacts ([11.1%]; p < 0.0001). HCWs who care for regular patients in the medium-risk group have also experienced a sustained higher risk of exposure to SARS-CoV-2. We should enhance the precaution against COVID-19 to protect HCW's safety through challenging times.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Seroprevalence of SARS-CoV-2 antibodies in vaccinated healthcare workers in Marrakech (Morocco)
    Ben Houmich, Taoufik
    Tali, Abdelali
    Debbagh, Fayrouz
    Hanchi, Asma Lamrani
    Soraa, Nabila
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2022, 36
  • [22] SARS-CoV-2 seroprevalence in healthcare workers and risk factors
    Weber, Stephanie
    Didelot, Alice
    Agrinier, Nelly
    Peyrin-Biroulet, Laurent
    Schvoerer, Evelyne
    Rabaud, Christian
    Jeulin, Helene
    INFECTION DISEASE & HEALTH, 2022, 27 (04) : 203 - 210
  • [23] SARS-CoV-2 seroprevalence among workers in a hospital in Madrid
    Perez-Garcia, Felipe
    Perez-Zapata, Aurora
    Arcos Varela, Naroa
    de la Mata Herrera, Manuel
    Ortiz Garcia, Maria
    Simon Ramos, Encarnacion
    Cakro Barzano, Carlos
    Clemente Garcia, Begone
    Garcia Miranda, Laura
    Martin Soto, Lorena
    Ropero Martinez, Maria
    Barrabes Bayascas, Rosa Maria
    Cuadros-Gonzalez, Juan
    REVISTA ESPANOLA DE SALUD PUBLICA, 2021, 95 : e1 - e14
  • [24] Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study
    Taher, Watheq Thabet
    Bawazir, Amen A.
    Sallam, Talal A.
    Alsurimi, Khaled
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [25] Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study
    Watheq Thabet Taher
    Amen A. Bawazir
    Talal A. Sallam
    Khaled Alsurimi
    BMC Infectious Diseases, 23
  • [26] Seroprevalence and Correlates of SARS-CoV-2 Antibodies in Health Care Workers in Chicago
    Wilkins, John T.
    Gray, Elizabeth L.
    Wallia, Amisha
    Hirschhorn, Lisa R.
    Zembower, Teresa R.
    Ho, Joyce
    Kalume, Naomi
    Agbo, Ojoma
    Zhu, Alex
    Rasmussen-Torvik, Laura J.
    Khan, Sadiya S.
    Carnethon, Mercedes
    Huffman, Mark
    Evans, Charlesnika T.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (01):
  • [27] Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in France
    Decarreaux, Dorine
    Pouquet, Marie
    Souty, Cecile
    Vilcu, Ana-Maria
    Prevot-Monsacre, Pol
    Fourie, Toscane
    Villarroel, Paola Mariela Saba
    Priet, Stephane
    Blanche, Helene
    Sebaoun, Jean-Marc
    Deleuze, Jean-Francois
    Turbelin, Clement
    Werner, Andreas
    Kochert, Fabienne
    Grosgogeat, Brigitte
    Rabiega, Pascaline
    Laupie, Julien
    Abraham, Nathalie
    Guerrisi, Caroline
    Noel, Harold
    van der Werf, Sylvie
    Carrat, Fabrice
    Hanslik, Thomas
    Charrel, Remi
    de Lamballerie, Xavier
    Blanchon, Thierry
    Falchi, Alessandra
    VIRUSES-BASEL, 2022, 14 (05):
  • [28] Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a pediatric monographic hospital in Madrid (Spain)
    Escribano Ceruelo, Eva
    Espinel Ruiz, Marco Antonio
    Ortega Lopez-Pelaez, Marta
    Fernandez Garoz, Barbara
    Asensio Anton, Julia
    Jimenez Garcia, Raquel
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2022, 40 (06): : 326 - 329
  • [29] SARS-CoV-2 Seroprevalence in Healthcare Workers before the Vaccination in Poland: Evolution from the First to the Second Pandemic Outbreak
    Korona-Glowniak, Izabela
    Mielnik, Michal
    Podgajna, Martyna
    Grywalska, Ewelina
    Hus, Marek
    Matuska, Katarzyna
    Wojtysiak-Duma, Beata
    Duma, Dariusz
    Glowniak, Andrzej
    Malm, Anna
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (04)
  • [30] Seroprevalence of Antibodies Against SARS-CoV-2 Among Health Care Workers in Mumbai, India
    Kumar, Nishant
    Bhartiya, Shibal
    Desai, Shashank
    Mutha, Amit
    Beldar, Amit
    Singh, Tarundeep
    ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH, 2021, 33 (01) : 126 - 128